4BD9 image
Deposition Date 2012-10-05
Release Date 2013-07-17
Last Version Date 2024-11-13
Entry Detail
PDB ID:
4BD9
Title:
Structure of the complex between SmCI and human carboxypeptidase A4
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.25
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 65 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CARBOXYPEPTIDASE A4
Gene (Uniprot):CPA4
Chain IDs:A
Chain Length:310
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Molecule:CARBOXYPEPTIDASE INHIBITOR SMCI
Mutations:YES
Chain IDs:B
Chain Length:165
Number of Molecules:1
Biological Source:SABELLASTARTE MAGNIFICA
Ligand Molecules
Primary Citation
A Noncanonical Mechanism of Carboxypeptidase Inhibition Revealed by the Crystal Structure of the Tri-Kunitz Smci in Complex with Human Cpa4.
Structure 21 1118 ? (2013)
PMID: 23746805 DOI: 10.1016/J.STR.2013.04.021

Abstact

The crystal structure of SmCI (Sabellastarte magnifica carboxypeptidase inhibitor) has been determined in complex with human carboxypeptidase A4 (hCPA4). SmCI is composed by three BPTI/Kunitz domains, each one displaying high structural homology and functionality with serine protease inhibitors. Moreover, SmCI possesses a distinctive capability to inhibit metallo-carboxypeptidases, constituting a bifunctional metallocarboxy- and serine protease inhibitor. The structure of the 1:1 complex of SmCI with hCPA4 reveals a noncanonical mechanism of carboxypeptidase inhibition, which surprisingly occurs mainly via the N-terminal segment, which penetrates into the active site groove of the enzyme. Mutagenesis and biochemical analysis confirm the major role of the N-terminal segment in the inhibition of carboxypeptidases. SmCI represents a tri-Kunitz serine protease inhibitor adapted to inhibit metallo-carboxypeptidases and discloses an unusual mechanism of inhibition by the N-terminal segment, emulating the "classical" C-terminal substrate-like inhibition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures